When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Suvorexant - Wikipedia

   en.wikipedia.org/wiki/Suvorexant

   Suvorexant is used for the treatment of insomnia, characterized by difficulties with sleep onset and/or sleep maintenance, in adults. [2] [6] At a dose of 15 to 20 mg and in terms of treatment–placebo difference, it reduces time to sleep onset by up to 10 minutes, reduces time awake after sleep onset by about 15 to 30 minutes, and increases total sleep time by about 10 to 20 minutes. [2]

3. Zolpidem - Wikipedia

   en.wikipedia.org/wiki/Zolpidem

   Zolpidem, sold under the brand name Ambien among others, is a medication primarily used for the short-term treatment of sleeping problems. [11] [16] Guidelines recommend that it be used only after cognitive behavioral therapy for insomnia and after behavioral changes, such as sleep hygiene, have been tried.

4. Somnifacient - Wikipedia

   en.wikipedia.org/wiki/Somnifacient

   Etizolam is a benzodiazepine somnifacient for treating insomnia. Somnifacient (from Latin somnus, sleep [1]), also known as sedatives or sleeping pills, is a class of medications that induces sleep. It is mainly used for treatment of insomnia.

5. Ramelteon - Wikipedia

   en.wikipedia.org/wiki/Ramelteon

   Ramelteon, sold under the brand name Rozerem among others, is a melatonin agonist medication which is used in the treatment of insomnia. [3] [5] It is indicated specifically for the treatment of insomnia characterized by difficulties with sleep onset. [3] It reduces the time taken to fall asleep, but the degree of clinical benefit is small. [6]

6. The Best Way to Treat Insomnia - AOL

   www.aol.com/best-way-treat-insomnia-160705363.html

   A role for medication. Clinical practice guidelines from the American Academy of Sleep Medicine consistently recommend CBT-I as the first-line treatment for chronic insomnia. “There are multiple ...

7. Lemborexant - Wikipedia

   en.wikipedia.org/wiki/Lemborexant

   Lemborexant is used in the treatment of insomnia in adults. [3]A major systematic review and network meta-analysis of medications for the treatment of insomnia published in 2022 found that lemborexant had an effect size (standardized mean difference (SMD)) against placebo for treatment of insomnia at 4 weeks of 0.36 (95% CI Tooltip confidence interval 0.08 to 0.63) and at 3 months of 0.41 (95% ...